The evolution of proton beam therapy: Current and future status.
暂无分享,去创建一个
Yong Hou | Jian Cheng | Xiufang Tian | Kun Liu | Jiandong Zhang | Jian Cheng | Xiufang Tian | Yong Hou | Kun Liu | Jian-dong Zhang
[1] T. Björk-Eriksson,et al. Does electron and proton therapy reduce the risk of radiation induced cancer after spinal irradiation for childhood medulloblastoma? A comparative treatment planning study , 2005, Acta oncologica.
[2] K. Shirai,et al. Dose-volume histogram parameters and clinical factors associated with pleural effusion after chemoradiotherapy in esophageal cancer patients. , 2011, International journal of radiation oncology, biology, physics.
[3] J. Slater,et al. Partial breast irradiation delivered with proton beam: results of a phase II trial. , 2011, Clinical breast cancer.
[4] Barbara L. Smith,et al. Accelerated partial-breast irradiation using proton beams: initial clinical experience. , 2006, International journal of radiation oncology, biology, physics.
[5] R. Collins,et al. Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomised trials , 2005, The Lancet.
[6] H. Sakurai,et al. Clinical Results of Proton-Beam Therapy for Locoregionally Advanced Esophageal Cancer , 2010, Strahlentherapie und Onkologie.
[7] H. Tsujii,et al. Proton beam therapy with high-dose irradiation for superficial and advanced esophageal carcinomas. , 2003, Clinical cancer research : an official journal of the American Association for Cancer Research.
[8] H. Sandler,et al. Comparative effectiveness study of patient‐reported outcomes after proton therapy or intensity‐modulated radiotherapy for prostate cancer , 2014, Cancer.
[9] Joe Y. Chang,et al. Early findings on toxicity of proton beam therapy with concurrent chemotherapy for nonsmall cell lung cancer , 2011, Cancer.
[10] T. Sakae,et al. Comparison of dose–volume histograms between proton beam and X-ray conformal radiotherapy for locally advanced non-small-cell lung cancer , 2014, Journal of radiation research.
[11] K. Hoffman,et al. National trends and determinants of proton therapy use for prostate cancer: A National Cancer Data Base study , 2016, Cancer.
[12] Harald Paganetti,et al. Relative biological effectiveness (RBE) values for proton beam therapy. , 2002, International journal of radiation oncology, biology, physics.
[13] Daniel W. Miller,et al. Proton radiation for treatment of cancer of the oropharynx: early experience at Loma Linda University Medical Center using a concomitant boost technique. , 2005, International journal of radiation oncology, biology, physics.
[14] Tatsuya Nakamura,et al. Clinical results of proton beam therapy for twenty older patients with esophageal cancer , 2015, Radiology and oncology.
[15] Stanley J. Rosenthal,et al. Neuroendocrine tumors of the sinonasal tract , 2002, Cancer.
[16] Hisao Ito,et al. Late toxicity after definitive concurrent chemoradiotherapy for thoracic esophageal carcinoma. , 2009, International journal of radiation oncology, biology, physics.
[17] M. Socinski,et al. High-dose conformal radiotherapy for treatment of stage IIIA/IIIB non-small-cell lung cancer: technical issues and results of a phase I/II trial. , 2002, International journal of radiation oncology, biology, physics.
[18] Uwe Schneider,et al. Potential reduction of the incidence of radiation-induced second cancers by using proton beams in the treatment of pediatric tumors. , 2002, International journal of radiation oncology, biology, physics.
[19] H. Ishikawa,et al. High-dose concurrent chemo–proton therapy for Stage III NSCLC: preliminary results of a Phase II study , 2014, Journal of radiation research.
[20] H. Paganetti,et al. Comparison of second cancer risk due to out-of-field doses from 6-MV IMRT and proton therapy based on 6 pediatric patient treatment plans. , 2011, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[21] H. Ishikawa,et al. Proton beam therapy in Japan: current and future status. , 2016, Japanese journal of clinical oncology.
[22] A. Taghian,et al. Accelerated partial breast irradiation using proton beams: Initial dosimetric experience. , 2006, International journal of radiation oncology, biology, physics.
[23] Joe Y. Chang,et al. Phase 2 study of high‐dose proton therapy with concurrent chemotherapy for unresectable stage III nonsmall cell lung cancer , 2011, Cancer.
[24] R. Mulhern,et al. Modeling radiation dosimetry to predict cognitive outcomes in pediatric patients with CNS embryonal tumors including medulloblastoma. , 2006, International journal of radiation oncology, biology, physics.
[25] J. Cox,et al. Are the results of RTOG 0617 mysterious? , 2012, International journal of radiation oncology, biology, physics.
[26] J. Pulido,et al. Cost-Effectiveness of Proton Beam Therapy for Intraocular Melanoma , 2015, PloS one.
[27] C. Pepine,et al. Valvular dysfunction and carotid, subclavian, and coronary artery disease in survivors of hodgkin lymphoma treated with radiation therapy. , 2003, JAMA.
[28] A. Berman,et al. Proton Beam Therapy for Non-Small Cell Lung Cancer: Current Clinical Evidence and Future Directions , 2015, Cancers.
[29] J. Buchsbaum,et al. Pediatric CSI: are protons the only ethical approach? , 2013, International journal of radiation oncology, biology, physics.
[30] R. Reiazi,et al. A Literature Survey on Cost-Effectiveness of Proton Beam Therapy in the Management of Breast Cancer Patients , 2015, Iranian journal of cancer prevention.
[31] T. Hashimoto,et al. Outcomes and prognostic factors for recurrence after high-dose proton beam therapy for centrally and peripherally located stage I non--small-cell lung cancer. , 2014, Clinical lung cancer.
[32] U. Isacsson,et al. Node-positive left-sided breast cancer patients after breast-conserving surgery: potential outcomes of radiotherapy modalities and techniques. , 2002, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[33] T. Hashimoto,et al. Comparison of adverse effects of proton and X-ray chemoradiotherapy for esophageal cancer using an adaptive dose–volume histogram analysis , 2015, Journal of radiation research.
[34] A. Lomax,et al. Radiation Oncology BioMed Central Review Radiation therapy planning with photons and protons for early and advanced breast cancer: an overview , 2006 .
[35] Andrew K. Lee,et al. Proton Beam Therapy for the Treatment of Prostate Cancer , 2014, Cancer journal.
[36] Alfred R. Smith,et al. Treatment planning with protons for pediatric retinoblastoma, medulloblastoma, and pelvic sarcoma: how do protons compare with other conformal techniques? , 2005, International journal of radiation oncology, biology, physics.
[37] M. Kasami,et al. High-dose proton beam therapy for sinonasal mucosal malignant melanoma , 2014, Radiation oncology.
[38] P. Johnstone,et al. Clinical Benefits of Proton Beam Therapy for Tumors of the Skull Base. , 2016, Cancer control : journal of the Moffitt Cancer Center.
[39] Ulf Isacsson,et al. Economic evaluation of proton radiation therapy in the treatment of breast cancer. , 2005, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[40] H. Shih,et al. Second nonocular tumors among survivors of retinoblastoma treated with contemporary photon and proton radiotherapy , 2014, Cancer.
[41] J. Slater,et al. A Technique of Partial Breast Irradiation Utilizing Proton Beam Radiotherapy: Comparison with Conformal X-Ray Therapy , 2007, Cancer journal.
[42] M. Socinski,et al. Randomized phase II trial of induction chemotherapy followed by concurrent chemotherapy and dose-escalated thoracic conformal radiotherapy (74 Gy) in stage III non-small-cell lung cancer: CALGB 30105. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[43] J. Loeffler,et al. Proton radiation therapy for primary sphenoid sinus malignancies: Treatment outcome and prognostic factors , 2009, Head & neck.
[44] J. Fowler,et al. Primary analysis of the phase II component of a phase I/II dose intensification study using three-dimensional conformal radiation therapy and concurrent chemotherapy for patients with inoperable non-small-cell lung cancer: RTOG 0117. , 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[45] J H LAWRENCE,et al. Pituitary irradiation with high-energy proton beams: a preliminary report. , 1958, Cancer research.
[46] A. Taghian,et al. Dosimetric comparison of proton and photon three-dimensional, conformal, external beam accelerated partial breast irradiation techniques. , 2006, International journal of radiation oncology, biology, physics.
[47] K. Sheng,et al. Size matters: a comparison of T1 and T2 peripheral non-small-cell lung cancers treated with stereotactic body radiation therapy (SBRT). , 2010, The Journal of thoracic and cardiovascular surgery.
[48] Yoshihiro Takai,et al. A phase II study on stereotactic body radiotherapy for stage I non-small cell lung cancer. , 2007, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[49] R. Wilson. Radiological use of fast protons. , 1946, Radiology.
[50] Johannes A Langendijk,et al. Potential benefits of scanned intensity-modulated proton therapy versus advanced photon therapy with regard to sparing of the salivary glands in oropharyngeal cancer. , 2011, International journal of radiation oncology, biology, physics.
[51] Ronald C. Chen,et al. Intensity-modulated radiation therapy, proton therapy, or conformal radiation therapy and morbidity and disease control in localized prostate cancer. , 2012, JAMA.
[52] Steven H. Lin,et al. Improving Outcomes for Esophageal Cancer using Proton Beam Therapy. , 2016, International journal of radiation oncology, biology, physics.
[53] K. Muro,et al. Phase II study of chemoradiotherapy with 5-fluorouracil and cisplatin for Stage II-III esophageal squamous cell carcinoma: JCOG trial (JCOG 9906). , 2011, International journal of radiation oncology, biology, physics.
[54] J. Ashman,et al. Proton beam therapy for locally advanced lung cancer: A review. , 2014, World journal of clinical oncology.
[55] A. Lomax,et al. Potential role of intensity-modulated photons and protons in the treatment of the breast and regional nodes. , 2003, International journal of radiation oncology, biology, physics.
[56] Alfred R. Smith,et al. The more important heavy charged particle radiotherapy of the future is more likely to be with heavy ions rather than protons. , 2013, Medical physics.
[57] B. Fullerton,et al. Proton radiotherapy for orbital rhabdomyosarcoma: clinical outcome and a dosimetric comparison with photons. , 2005, International journal of radiation oncology, biology, physics.
[58] Gary A Ezzell,et al. The clinical case for proton beam therapy , 2012, Radiation oncology.
[59] Steven H. Lin,et al. Proton beam therapy for the treatment of esophageal cancer. , 2016, Chinese clinical oncology.
[60] W. H. Bragg,et al. XXXIX. On the α particles of radium, and their loss of range in passing through various atoms and molecules , 1905 .
[61] T. Sakae,et al. Designed-seamless irradiation technique for extended whole mediastinal proton-beam irradiation for esophageal cancer , 2012, Radiation oncology.
[62] K. Goto,et al. Dosimetric comparison between proton beam therapy and photon radiation therapy for locally advanced non-small cell lung cancer. , 2016, Japanese Journal of Clinical Oncology.
[63] Nicholas G Zaorsky,et al. Evolution of advanced technologies in prostate cancer radiotherapy , 2013, Nature Reviews Urology.
[64] Steven L. Chang,et al. Survival Analyses of Patients With Metastatic Renal Cancer Treated With Targeted Therapy With or Without Cytoreductive Nephrectomy: A National Cancer Data Base Study. , 2016, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[65] Tatsuya Nakamura,et al. Preliminary treatment results of proton beam therapy with chemoradiotherapy for stage I–III esophageal cancer , 2016, Cancer medicine.
[66] S. Hancock,et al. Screening for coronary artery disease after mediastinal irradiation for Hodgkin's disease. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[67] K. Kagei,et al. Clinical results of proton beam therapy for cancer of the esophagus. , 2005, International journal of radiation oncology, biology, physics.
[68] W. Curran,et al. Standard-dose versus high-dose conformal radiotherapy with concurrent and consolidation carboplatin plus paclitaxel with or without cetuximab for patients with stage IIIA or IIIB non-small-cell lung cancer (RTOG 0617): a randomised, two-by-two factorial phase 3 study. , 2015, The Lancet. Oncology.
[69] Radhe Mohan,et al. Stray radiation dose and second cancer risk for a pediatric patient receiving craniospinal irradiation with proton beams , 2009, Physics in medicine and biology.
[70] Narikazu Boku,et al. Long-term toxicity after definitive chemoradiotherapy for squamous cell carcinoma of the thoracic esophagus. , 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.